Human beings seek inspiration from every possible source around them. This inspiration plays a big role in driving us forward towards a better version of ourselves. Now, over the course of our life, we interact with many such driving forces, but none have intrigued us like knowledge. The idea of knowing more about the world, and about us, motivates us to keep moving when things get a little tough. While these knowledge-driven pursuits don’t always lead to something productive, it must be acknowledged that they have given us a fair few notable dividends, and the most prominent of them all is technology. Technology, as we know, is constructed around many different concepts and principles. The heavy segmentation within its core does everything to bolster the creation’s versatility. Nevertheless, if there is one element, which binds all the pillars of technology together, it’s the informative value in play across the board. No matter what tech discipline you might be zooming upon at a given time, you are more than likely to learn a new dynamic from it. This is just how the cookie has crumbled for technology since the beginning, and even after so long, the trend remains very much active. In fact, to scale things up, we are now reinvesting whatever the world has got from technology to speed up the creation’s own evolution. A latest example of it appeared in the medical sector.
NextSense, a foundation for brain health, has announced that it’s working on a biosensing earbuds’ technology, which will look to create a comprehensive data pool for better overall treatment of brain-related complications like epilepsy. The primary intention here is to help medical professionals with a bigger sample size, therefore enabling them in terms of picking the right response for a particular situation. So far, we haven’t had this privilege due to a lack of more universal devices. As a result, the professionals would be pretty much forced to put their stock in data collected from a limited timeframe. The biosensing earbuds solve such a conundrum by offering an effective avenue from both cost, as well as comfort standpoint.
To realize the project, NextSense has partnered with Emory University, and biopharma company, UCB. Apart from that, it has also signed research and IP agreements with UC San Diego and Heraeus.
“Whether someone is living with epilepsy, struggling to stay alert, or seeking an elusive diagnosis for a neurological condition, we’re offering hope,“ said Jen Dwyer, Medical Director of NextSense. “We see our members from every angle, and we understand their unique pain points. We’re working towards a world where those who suffer from these conditions don’t have to choose between comfort and accuracy. And we’re just getting started.”
At present, NextSense is recruiting participants for the device’s clinical trials focused on epilepsy and sleep. However, assuming things go as per the plan, these biosensing earbuds can very well branch out and become an attractive prospect to treat various other brain diseases.
